Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02736929 · ClinicalTrials.gov registry record · NA

The Effect of Reducing Posttraumatic Stress Disorder Symptoms on Cardiovascular Risk

A NA study of PTSD, sponsored by Duke University.

Completed
Registry status
NA
Development phase
112
Enrollment target
1
Study location

NCT02736929 is a NA study of PTSD that has completed, run by Duke University. The registered enrollment target is 112 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02736929, a NA study of PTSD, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target
1
Study location

Study Summary

Some individuals who are exposed to traumatic events experience both psychological and cardiovascular changes that affect their health and well-being. The purpose of this study is to learn more about how reducing the psychological symptoms (such as those that occur with posttraumatic stress disorder, or PTSD) affects cardiovascular systems that regulate heart and blood pressure.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Processing Therapy - Cognitive

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2016-04
Est. Completion 2021-07-20
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT02736929

The ClinicalTrials.gov registry entry for NCT02736929 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (63% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Processing Therapy - Cognitive is the first listed.

NCT02736929 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02736929 about?

NCT02736929 is a clinical study titled "The Effect of Reducing Posttraumatic Stress Disorder Symptoms on Cardiovascular Risk". Some individuals who are exposed to traumatic events experience both psychological and cardiovascular changes that affect their health and well-being. The purpose of this study is to learn more about how reducing the psychological symptoms (such as those that occur with posttraumatic stress disorder...

What is the current status of trial NCT02736929?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2016-04. Estimated completion is 2021-07-20.

What conditions does trial NCT02736929 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT02736929?

The interventions under investigation include: Cognitive Processing Therapy - Cognitive (BEHAVIORAL).

Who is sponsoring clinical trial NCT02736929?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02736929 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.